Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling

Circulation

Volumn 101, Issue 2, 2000, Pages 200-206

  Lee, Shih Huang ^a   Yu, Wen Chung ^b   Cheng, Jun Jack ^a   Hung, Chi Ren ^a   Ding, Yu An ^b   Chang, Mau Song ^b   Chen, Shin Ann ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Atrium; Electrophysiology; Tachycardia

Indexed keywords

VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROPHYSIOLOGY; HEART ATRIUM FIBRILLATION; HEART PACING; NONHUMAN; PRIORITY JOURNAL; REFRACTORY PERIOD; TACHYCARDIA;

EID: 0033962885     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.2.200     Document Type: Article

References (33)

1. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91: 1588-1595.
2. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
3. Elvan A, Wylie K, Zipes DP. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs: electrophysiological remodeling. Circulation. 1996;94:2953-2960.
4. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation. 1996;94: 2968-2974.
5. Tieleman RG, De Langen CDJ, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, Wijffels MCEF, Allessie MA, Crijns HJGM. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation. 1997; 95:1945-1953.
6. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation. 1997;96:3710-3720.
7. Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation. 1997;96:4027-4035.
8. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation. 1998;98: 2202-2209.
9. Wiener N, Rosenblueth A. The mathematical formulation of the problem of conduction of impulses in a network of connected excitable elements, specially in cardiac muscle. Arch Inst Cardiol Mex. 1946;16:205-265.
10. Smeets JLRM, Allessie MA. Lammers WJEP, Bonke FIM, Hollen SJ. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium: the role of heart rate, autonomic transmitters, temperature and potassium. Circ Res. 1986;58:96-108.
11. Rensma PL, Allessie MA, Lammers WJEP, Bonke FIM, Schalij MJ. Length of the excitation wave as an index for the susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res. 1988; 62:395-410.
12. Daoud EG, Knight BP, Weiss R, Bahu M, Paladino W, Goyal R, Man KC, Strickberger SA, Morady F. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation. 1997;96:1542-1550.
13. Lee SH, Lin FY, Yu WC, Cheng JJ, Kuan P, Hung CR, Chang MS, Chen SA. Regional differences in the recovery course of tachycardia-induced changes of atrial electrophysiological properties. Circulation. 1999;99: 1255-1264.
14. Lee SH, Chen SA, Yu WC, Cheng JJ, Kaun P, Hung CR, Chang MS, Lin FY. Change of atrial refractory period after short duration of rapid atrial pacing: regional differences and possible mechanisms. Pacing Clin Electrophysiol. 1999;22:927-934.
15. Jose AD, Taylor RR. Automatic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest. 1989;48: 2019-2031.
16. Li H, Hare J, Mughal K, Krum D, Biehl M, Deshpande S, Dhala A, Blanck Z, Sra J, Jazayeri M, Akhtar M. Distribution of atrial electrogram types during atrial fibrillation: effect of rapid atrial pacing and intercaval junction ablation. J Am Coll Cardiol. 1996;27:1713-1721.
17. Attuel P, Childers RW, Haissaguerre M, Leclercq J, Mugica J, Coumel P. Failure in the rate adaptation of the atrial refractory periods: new parameter to assess atrial vulnerability. Pacing Clin Electrophysiol. 1984; 7:1382.
18. Le Heuzey J, Boutjdir M, Gagey S, Lavergne T, Guize L. Cellular aspects of atrial vulnerability. In: Attuel P, Olsson SB, Schlepper M, eds. The Atrium in Health and Disease. Mount Kisco, NY: Futura Publishing; 1989;81-94.
19. Moe GK. On the multiple wavelet hypothesis of AF. Arch Int Pharmacodyn Ther. 1962;140:183-188.
20. Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II. The role of non-uniform recovery of excitability in the occurrence of unidirectional block as studied with multiple microelectrodes. Circ Res. 1976;39:168-177.
21. Ramdat Misier AR, Opthof T, Van Hemel NM, Defauw JJAM, De Bakker JMT, Janse MJ, van Capelle FJL. Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol. 1992;19:1531-1535.
22. Ausma J. Wijffels MCEF, Thone F, Wouters L, Allessie MA, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997;96:3157-3163.
23. van der Velden HMW, van Kempen MJA, Wijffels MCEF, van Zijverden M, Groenewegen WA, Allessie MA, Jongsma HJ. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goal. J Cardiovasc Electrophysiol. 1998;9:596-607.
24. + current in a chronic dog model of atrial fibrillation. Circ Res. 1997;81:1045-1052.
25. Shenasa M, Kus T, Fromer M, LeBlanc RA, Dubuc M, Nadeau R. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol. 1988;62:403-407.
26. Isomoto S, Shimizu A, Konoe A, Tanigawa M, Kaibara M, Centurion OA, Fukatani M, Yano K. Effects of intravenous verapamil on atrial vulnerability. Jpn Circ J. 1994;58:1-8.
27. Singh BN, Hecht HS, Hademanee K, Chew CYC. Electrophysiologic and hemodynamic effects of slow-channel blocking drugs. Prog Cardiovasc Dis. 1982;25:103-132.
28. Kumagai K, Matsuo K, Ono M, Yamanouchi Y, Moroe K, Hamasaki N, Arakawa K. Effects of verapamil on electrophysiological properties in paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 1993;16: 309-316.
29. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiacmuscle. Circ Res. 1986;58:356-371.
30. Papageorgiou P, Monahan K, Boyle NG, Seifert MJ, Beswick P, Zebede J, Epstein LM, Josephson ME. Site-dependent intra-atrial conduction delay: relationship to initiation of atrial fibrillation. Circulation. 1996;94: 384-389.
31. Yu WC, Chen SA, Tai CT, Feng AN, Chang MS. Effects of different atrial pacing modes on atrial electrophysiology: implication the mechanism of biatrial pacing in prevention of atrial fibrillation. Circulation. 1997;96:2992-2996.
32. Rinkenberger RL, Prystowsky EN, Heger JJ, Troup PJ, Jackman WM, Zipes DP. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation. 1980;62:996-1010.
33. Waxman HL, Meyerburg RJ, Appel R, Sung RJ. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter. Ann Intern Med. 1981;94:1-6.